Tianda Pharmaceuticals Limited (HKG:0455)

Tianda Pharmaceuticals Revenue

Tianda Pharmaceuticals had revenue of 164.22M HKD in the half year ending June 30, 2026, with 5.22% growth. This brings the company's total for the last twelve months to 350.53M, up 12.89% year-over-year. In the year 2025, Tianda Pharmaceuticals had annual revenue of 322.95M, down -2.12%. That makes Tianda Pharmaceuticals the 28,753rd largest company in the world by revenue and 1,718th in Hong Kong.

• Revenue (ttm): 350.53M
• Revenue Growth: +12.89%
• P/S Ratio: 0.55
• Revenue / Employee: 611.75K
• Employees: 573
• Market Cap: 191.35M

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Pharmaceuticals and Medical Technologies Business (Excluding Chinese Medical Business) 249.28M 75.4%
• Chinese Medicine Business (Excluding Medical and Healthcare Services) 59.26M 17.9%
• Medical and Healthcare Services 22.23M 6.7%

By Geography

Chart

• Chinese Mainland 315.14M 97.6%
• Hong Kong 6.39M 2.0%
• Australia 1.42M 0.4%

Fiscal year ended Dec 31, 2025 See the full Tianda Pharmaceuticals breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	322.95M	-6.99M	-2.12%
Dec 31, 2024	329.94M	-202.15M	-37.99%
Dec 31, 2023	532.09M	-14.61M	-2.67%
Dec 31, 2022	546.69M	36.74M	7.20%
Mar 31, 2022	509.96M	35.62M	7.51%

Data Source: S&P Global Market Intelligence Last updated: Sep 29, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 31, 2026

Data Sources Report a data error